FDA Drug recall D-1407-2015
Tri-Est 80:10:10 Progesterone (estriol, estradiol, estrone, progesterone) capsules Rx only, Manufactured by Park Compounding, Irvine, CA
- FDA Drug
- Class II
- terminated
- Published 2015-09-09
On 2015-09-09 the FDA classified a Class II recall of Tri-Est 80:10:10 Progesterone (estriol, estradiol, estrone, progesterone) capsules Rx only, Manufactured by Park Compounding, Irvine, CA by South Coast Specialty Compounding, citing penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1407-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-04-23 |
| Published | 2015-09-09 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | South Coast Specialty Compounding |
| Distribution | US |
Product
Tri-Est 80:10:10 Progesterone (estriol, estradiol, estrone, progesterone) capsules Rx only, Manufactured by Park Compounding, Irvine, CA
Reason
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Identifiers
| code_info | All Lots, Exp 09/15 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1407-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.